Siltuximab

(Sylvant^®) Approved

An interleukin 6 (IL-6) inhibitor used to teat multicentric Castleman’s disease.

Research Code CNTO-328; cCLB-8

CAS No. 541502-14-1

Follitropin alfa biosimilar (Finox Biotech)

(Bemfola^®) Approved

A recombinant human follicle stimulating hormone (FSH) used in women undergoing controlled ovarian stimulation during infertility treatment and hypogonadotropic hypogonadism in men.

Research Code

CAS No. 146479-72-3

Insulin human (inhalation powder)

(Afrezza, Afresa, Technosphere Insulin System^®) Approved

A rapid acting inhaled insulin used to improve glycemic control in adult patients with diabetes mellitus.

Research Code SAR-439065

CAS No. 11061-68-0 (Recombinant insulin Human)

Polyethylene glycol recombinant human somatropin

(Jintrolong, 金赛增^®) Approved

A pegylated recombinant human growth hormone (GH) used to treat pediatric growth retardation.

Research Code GenSci-004

CAS No. 1088845-67-3

Meningococcal group B vaccine (Pfizer)

(Trumenba^®) Approved

A recombinant lipidated vaccine used to prevent meningococcal group B infections.

Research Code MnBrLP-2086; PF-05212366; PF-5212366; Rlp-2086

CAS No.

Efmoroctocog alfa/Efraloctocog alfa

(Elocta, Eloctate^®) Approved

A recombinant Fc-human blood coagulation factor VIII fusion protein indicated for the treatment and prevention of bleeding in patients with hemophilia A.

Research Code BIIB-031; rFVIIIFc

CAS No. 1270012-79-7

Human papillomavirus 9-valent vaccine, recombinant (Merck & CO.)

(Gardasil 9^®) Approved

A nine-valent human papillomavirus (HPV) L1 virus-like particle (VLP) vaccine used to prevent anal cancer, cervical cancer, vulvovaginal cancer, genital warts caused by human papillomavirus infection.

Research Code V-503

CAS No.

Blinatumomab

(Blincyto^®) Approved

A bispecific CD19-directed CD3 T-cell engager used to treat philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Research Code AMG-103; MEDI-538; MT-103; BiTE-MT-103; bscCD19xCD3

CAS No. 853426-35-4

Peginterferon beta-1a

(Plegridy^®) Approved

A PEGylated recombinant interferon β-1a used to treat relapsing forms of multiple sclerosis.

Research Code BIIB-017; PEG-IFN-beta-1a

CAS No. 1211327-92-2

Insulin glargine

(Basaglar, Abasaglar, Abasria^®) Approved

A long-acting human insulin analog used to improve glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes.

Research Code LY-2963016; LY2963016-U-100; LY2963016-U-200

CAS No. 160337-95-1

Belinostat

(Beleodaq^®) Approved

A histone deacetylase (HDAC) inhibitor used to treat relapsed or refractory peripheral T-cell lymphoma (PTCL).

Research Code PDX 101; PXD-101; PX-105684; CLN-9

CAS No. 866323-14-0(Belinostat)

Simoctocog alfa/Antihemophilic Factor (Recombinant)

(Nuwiq, Vihuma^®) Approved

A recombinant coagulation factor VIII indicated for the treatment and prevention of bleeding in patients with hemophilia A.

Research Code Human-cl rhFVIII; Factor VIII 

CAS No. 1219013-68-9

Vedolizumab

(Entyvio^®) Approved

An integrin α4β7 antagonist used to treat adult ulcerative colitis and adult Crohn's disease.

Research Code MLN-002; MLN-0002; MLN-02; LPD-02; LDP-02; Anti-beta7-MAb

CAS No. 943609-66-3

Secukinumab

(Cosentyx^®) Approved

An interleukin 17A (IL-17A) inhibitor used to teat moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis.

Research Code AIN-457; NVP-AIN 457; KB-03303A

CAS No. 1229022-83-6

Ripasudil Hydrochloride Hydrate

(Glanatec^®) Approved

A Rho kinase (RhoK) inhibitor used to treat glaucoma and ocular hypertension.

Research Code K-115; K-115-R

CAS No. 887375-67-9(Ripasudil HCl Dihydrate)  223645-67-8(Ripasudil)

Luseogliflozin Hydrate

(Lusefi^®) Approved

A sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

Research Code TS-071; TS-71

CAS No. 898537-18-3(Luseogliflozin)

Dalbavancin Hydrochloride

(Dalvance, Xydalba, Zeven^®) Approved

A cell wall inhibitor used to treat acute bacterial skin and skin structure infections (ABSSSI) in adults caused by Gram-positive organisms.

Research Code BI-397; BI-397 factor B0; MDL-63397; VER-001

CAS No. 171500-79-1(Dalbavancin（B0）)

Vonoprazan Fumarate

(Takecab, Vonopion pack, Vonosap pack 400, Vonosap pack 800^®) Approved

A proton pump inhibitor (PPI) used to treat gastric ulcer, duodenal ulcer and reflux esophagitis.

Research Code TAK-438

CAS No. 1260141-27-2(Vonoprazan Fumarate)  881681-00-1(Vonoprazan)

Ipragliflozin L-Proline

(Suglat^®) Approved

A sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

Research Code ASP-1941

CAS No. 951382-34-6(Ipragliflozin L-Proline)  761423-87-4(Ipragliflozin)

Tofogliflozin Hydrate

(Deberza, Apleway^®) Approved

A sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

Research Code CSG-452; R-7201; RG-7201; RO4998452

CAS No. 1201913-82-7(Tofogliflozin Monohydrate)  903565-83-3(Tofogliflozin)